Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
09/2010
09/14/2010US7795299 11,15-dioxa-cyclopenta[a]phenanthren-12-one derivatives, used for the treatment of cancer; anticarcinogenic agents
09/14/2010US7795260 ecteinascidin analogues used for the treatment of of leukaemia, lung cancer, colon cancer, kidney cancer, melanoma, prostate cancer, ovarian cancer, breast cancer, pancreatic epitheloid carcinoma, and cervix epitheloid carcinoma; antitumor and anticarcinogenic agents
09/14/2010US7795259 pyrrolo[2,3-b]pyrazine derivatives used as enzyme inhibitors for the treatment of cardiovascular disorders, diabetes, Alzheimer's disease, immunodeficiency disorders, inflammatory diseases, hypertension, allergic diseases, autoimmune diseases, bone disorders, cancer and viral diseases
09/14/2010US7795256 p38 mitogen-activated protein (MAP) kinase inhibitors such as Ethyl 3-(3-methylbenzoyl)-6-oxo-7-phenyl-6,7-dihydrothieno[2,3-b]pyridine-2-carboxylate, used in the treatment and/or prevention of autoimmune diseases or inflammatory disorders; antiinflammatory agents
09/14/2010CA2415558C Acid addition salts of hydropyridine derivatives
09/14/2010CA2409715C .beta.-carboline derivatives useful as inhibitors of phosphodiesterase
09/10/2010WO2010101302A1 Thienopyrimidine as cdc7 kinase inhibitors
09/10/2010WO2010101224A1 Organic semiconductor material and organic thin film transistor
09/10/2010WO2010101128A1 Amide compound
09/09/2010US20100228033 Method of manufacturing 5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate (prasugrel)
09/09/2010US20100227882 Clopidogrel salt and polymorphic forms thereof
09/08/2010EP1874781B9 Dihydrothienopyrimidines for the treatment of inflammatory diseases
09/08/2010CN1732154B Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
09/08/2010CN101827853A Heterocycle-substituted piperazino-dihydrothienopyrimidines
09/08/2010CN101827852A Substituted piperidino-dihydrothienopyrimidines
09/08/2010CN101827851A 5-cyano-thienopyridines for the treatment of tumors
09/08/2010CN101824043A Compositions useful as inhibitors of protein kinases
09/08/2010CN101824042A Triphenylamine-dithienoindene derivative with photovoltaic property
09/08/2010CN101823951A Process for the preparation of 2-ethyl-4,6-dimethylphenyl acetic acid
09/08/2010CN101250193B Method for preparing 2-methoxy-5-(alpha-cyclopropyl carbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothiophene [3,2-c] pyridine
09/08/2010CN101044123B Pyrimidine derivative fused with nonaromatic ring
09/07/2010US7790716 fatty acid biosynthesis inhibitors such as E)-3-(6-aminopyridin-3-yl)-N-methyl-N-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)acrylamide, used fro the treatment of bacterial infections; antibiotics
09/07/2010US7790713 Inhibitors of interleukin-1β converting enzyme
09/07/2010US7790709 Heterocyclic compounds, methods of making them and their use in therapy
09/07/2010US7789610 Methods for preventing/treating damage to sensory hair cells and cochlear neurons
09/07/2010CA2493680C Condensed heterocyclic pyrazole derivatives as kinase inhibitors
09/07/2010CA2370344C Thieno- and furopyrimidine derivatives as a2a-receptor antagonists
09/02/2010WO2010098372A1 Field effect transistor
09/02/2010WO2010098344A1 Tricyclic pyrazolopyrimidine derivative
09/02/2010WO2010098326A1 Novel compounds, process for preparing same, organic semiconductor materials, and organic semiconductor devices
09/02/2010WO2010097469A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/02/2010US20100222596 Kind of organic compound and organic dye used in dye-sensitized solar cell thereof
09/02/2010US20100222576 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
09/02/2010US20100222378 2-heteroarylcarboxylic acid amides
09/02/2010US20100222357 Indol-3-y-carbonyl-piperidin and piperazin-derivatives
09/02/2010US20100222342 Pyrrolopyrazole, potent kinase inhibitors
09/02/2010US20100222328 2-cyclopropyl-thiazole derivatives
09/02/2010US20100222326 New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders
09/02/2010CA2753304A1 Tricyclic pyrazolopyrimidine derivatives as hsp inhibitors
09/02/2010CA2751299A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/01/2010EP2223919A1 Nitrogen-containing heterocyclic compound and bactericide for agricultural and horticultural use
09/01/2010EP2102215B1 4,5,6,7-tetrahydro-thieno [2,3-c]pyridines as h3 modulators
09/01/2010EP1963337B1 THIENO[2,3-b]PYRIDINE DERIVATIVES
09/01/2010EP1635839B1 Benzo[4,5]thieno[2,3-d]pyrimidin-4-ones and their use in therapy
09/01/2010CN101821273A Heterocyclic compound, ultraviolet ray absorbent, and composition comprising the ultraviolet ray absorbent
09/01/2010CN101817888A Cyclic acetal base-containing thioxanthone photo initiator and preparation method thereof
09/01/2010CN101817834A Pyrazole derivatives and preparation method and application thereof
09/01/2010CN101817833A DPP-IV inhibitor
08/2010
08/31/2010US7786470 Switching element
08/31/2010US7786162 Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
08/31/2010US7786131 Anticancer agents; restenosis; atherosclerosis; skin disorders
08/31/2010US7786048 Condensed heterocyclic pyrazole derivatives as kinase inhibitors
08/26/2010WO2010094405A1 Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof
08/26/2010WO2010065825A3 Thieno [3, 2-c] pyridine derivatives as kinase inhibitors for use in the treatment of cancer
08/26/2010US20100216970 Methods, compositions, and apparatuses for forming macrocyclic compounds
08/26/2010US20100216820 Thienopyrimidiones for treatment of inflammatory disorders and cancers
08/26/2010US20100216807 Heterocyclic compounds as serotonergic and / or dopaminergic agents and uses thereof
08/26/2010US20100216789 Rho-kinase inhibitors
08/26/2010US20100215759 Pharmaceutical compounds
08/26/2010CA2752603A1 Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof
08/25/2010EP2221296A1 Fused indane compound
08/25/2010EP2220095A1 Inhibitors of human immunodeficiency virus replication
08/25/2010EP2220065A2 Modulators of ccr9 receptor and methods of use thereof
08/25/2010EP1910338B1 Heterotetracyclic compounds as tpo mimetics
08/25/2010EP1807434B1 Thienopyridines as allosteric potentiators of the m4 muscarinic receptor
08/25/2010EP1737844B1 Bicyclic anthranilamide derivatives useful as insecticides
08/25/2010EP1339402B1 Azaphenanthridone derivatives and their use as parp inhibitors
08/25/2010CN101815718A Pyridine derivatives and methods of use thereof
08/25/2010CN101812073A Method for preparing acethydrazide derivatives
08/25/2010CN101812072A Method for preparing anti-platelet aggregation compounds
08/25/2010CN101812071A Method for processing mother liquor obtained by splitting clopidogrel hydrogen sulfate intermediate
08/25/2010CN101812070A Prasugrel compound and new preparation method thereof
08/25/2010CN101812069A Process for synthesizing prasugrel
08/25/2010CA2694672A1 Pharmaceutical compounds
08/24/2010US7781431 Thienopyrroles as antiviral agents
08/19/2010WO2010092340A1 Fused pyridine and pyrazine derivatives as kinase inhibitors
08/19/2010WO2010092181A1 Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1
08/19/2010US20100210856 Dithiolopyrrolone compounds, the preparation and the use thereof
08/19/2010US20100210854 Cyclopropenones and the Photochemical Generation of Cyclic Alkynes Therefrom
08/19/2010US20100210762 Heterocyclic compound, ultraviolet absorbent and composition containing the same
08/19/2010US20100210685 Novel Substituted Indoles
08/19/2010US20100210679 Preventive and therapeutic medicament for gastroesophageal reflux disease
08/19/2010CA2750913A1 Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1
08/18/2010EP2218710A1 Procedure for the preparation of 2,6-diethyl-4-methylphenylacetic acid
08/18/2010EP2218330A1 Process for the preparation of 2-ethyl-4,6-dimethylphenyl acetic acid by reacting 2-ethyl-4,6-dimethylbromobenzene with tert.-butylacetate
08/18/2010EP2217604A1 Gamma secretase modulators
08/18/2010EP2217596A2 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119
08/18/2010EP1737842B1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs
08/18/2010CN101805355A Thienopyridone derivative, preparation method and uses thereof
08/18/2010CN101805354A Preparation method of I type clopidogrel hydrogen sulfate
08/18/2010CN101805309A Benzamide derivatives useful as histone deacetylase inhibitors
08/17/2010US7777055 Photochromic and electrochromic compounds and methods of synthesizing and using same
08/17/2010US7776874 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
08/17/2010US7776868 e.g. 6-[(1E)-2-(3,4-dimethoxyphenyl)vinyl]-3-ethyl-1,5-dimethyl-1,3-dihydrothiopheno[2,3-d]pyrimidine-2,4-dione; neurodegenerative disorders, antiischemic agent, antidepressant, attention deficit disorder, hepatic fibrosis, cirrhosis of the liver, and drug addiction
08/17/2010US7776867 Furanopyrimidines
08/17/2010US7776856 Fused pyrimidines such as 2-(1H-Indol -4-yl )-6-(4-methyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine, uses as phosphatidylinositol 3-kinase inhibitors, for the treatment of cancer, viral infection, inflammation, metabolic, endocrine, immune and cardiovascular disorders
08/17/2010US7776791 N-heterocyclyl phenyl-substituted cyclic ketoenols
08/17/2010CA2544443C Processes for preparing different forms of (s)-(+)-clopidogrel bisulfate
08/17/2010CA2378165C Dihydrobenzodiazepines and their use in the treatment of dyslipidaemia
08/17/2010CA2370412C Pharmaceutical compounds
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 214